Topical Treatment of Human Skin and Cultured Keratinocytes with High-Dose Spironolactone Reduces XPB Expression and Induces Toxicity.

MLA

Carpenter, M.Alexandra, and Michael G. Kemp. “Topical Treatment of Human Skin and Cultured Keratinocytes with High-Dose Spironolactone Reduces XPB Expression and Induces Toxicity.” JID Innovations : Skin Science from Molecules to Population Health, vol. 1, no. 3, May 2021, p. 100023. EBSCOhost, https://doi.org/10.1016/j.xjidi.2021.100023.

APA

Carpenter, M. A., & Kemp, M. G. (2021). Topical Treatment of Human Skin and Cultured Keratinocytes with High-Dose Spironolactone Reduces XPB Expression and Induces Toxicity. JID Innovations : Skin Science from Molecules to Population Health, 1(3), 100023. https://doi.org/10.1016/j.xjidi.2021.100023

Chicago

Carpenter, M Alexandra, and Michael G Kemp. 2021. “Topical Treatment of Human Skin and Cultured Keratinocytes with High-Dose Spironolactone Reduces XPB Expression and Induces Toxicity.” JID Innovations : Skin Science from Molecules to Population Health 1 (3): 100023. doi:10.1016/j.xjidi.2021.100023.